LifeStance appoints Dave Bourdon as CEO; Ken Burdick becomes Executive Chairman; Ryan McGroarty named CFO

LifeStance Health Group, Inc.

Dave Bourdon, CFO since 2022, becomes CEO effective March 3, 2025; Ryan McGroarty appointed CFO effective March 17, 2025.
Ken Burdick retires as CEO and becomes Executive Chairman, continuing on the Board.
Bourdon's new annual base salary is $700,000; target bonus 100% of salary for 2025.
McGroarty receives $550,000 base salary, $570,000 signing bonus, and $5M target equity award (RSUs and PSUs).
Both appointments follow nine consecutive quarters of meeting or exceeding financial expectations.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Kenneth Burdick

Executive Chairman

LFST · LifeStance Health Group, Inc.

Effective: 2025-03-03
Successor: David Bourdon
Filed: February 27, 2025, 6:59 PM ET

Mr. Bourdon will succeed Kenneth Burdick, who has served as the Company’s Chief Executive Officer since 2022 and who is retiring from his position, effective as of the CEO Start Date.

Role change

David Bourdon

Chief Executive Officer

LFST · LifeStance Health Group, Inc.

Effective: 2025-03-03
Successor: Ryan McGroarty
Filed: February 27, 2025, 6:59 PM ET

promoted David Bourdon to serve as the Company’s Chief Executive Officer effective as of March 3, 2025

Appointed

Ryan McGroarty

Chief Financial Officer and Treasurer

LFST · LifeStance Health Group, Inc.

Effective: 2025-03-17
Filed: February 27, 2025, 6:59 PM ET

the Board of Directors also appointed Ryan McGroarty as the Company’s Chief Financial Officer and Treasurer, effective as of March 17, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kenneth Burdick retired as Executive Chairman at LifeStance Health Group, Inc..

Action: retired
Role: Executive Chairman

Exact text from the filing

Mr. Bourdon will succeed Kenneth Burdick, who has served as the Company’s Chief Executive Officer since 2022 and who is retiring from his position, effective as of the CEO Start Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Bourdon changed role as Chief Executive Officer at LifeStance Health Group, Inc..

Action: promoted
Role: Chief Executive Officer

Exact text from the filing

promoted David Bourdon to serve as the Company’s Chief Executive Officer effective as of March 3, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan McGroarty was appointed as Chief Financial Officer and Treasurer at LifeStance Health Group, Inc..

Action: appointed
Role: Chief Financial Officer and Treasurer

Exact text from the filing

the Board of Directors also appointed Ryan McGroarty as the Company’s Chief Financial Officer and Treasurer, effective as of March 17, 2025

View on SEC.gov

LifeStance Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-037533

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.